Foundry Partners, LLC - HORIZON PHARMA PLC ownership

HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 5.0%.

Quarter-by-quarter ownership
Foundry Partners, LLC ownership history of HORIZON PHARMA PLC
ValueSharesWeighting
Q1 2019$3,174,000
-31.7%
120,095
-49.4%
0.13%
+32.3%
Q4 2018$4,647,000
+116.2%
237,571
+116.5%
0.10%
+17.1%
Q3 2018$2,149,000
+18.1%
109,730
-0.2%
0.08%
+10.8%
Q2 2018$1,820,000
+9.7%
109,901
-5.9%
0.07%
+4.2%
Q1 2018$1,659,000116,8510.07%
Other shareholders
HORIZON PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Broadfin Capital, LLC 5,959,819$96,430,00010.71%
Consonance Capital Management LP 5,793,903$93,745,00010.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 8,956,988$144,924,0005.96%
JW Asset Management, LLC 507,075$8,205,0005.46%
KINGDON CAPITAL MANAGEMENT, L.L.C. 6,682,618$108,125,0005.23%
NEXTHERA CAPITAL LP 500,000$8,090,0004.74%
Lion Point Capital, LP 1,164,414$18,840,0004.58%
KINGDON CAPITAL MANAGEMENT, L.L.C. 4,503,900$72,873,0003.52%
ARMISTICE CAPITAL, LLC 650,000$10,517,0002.49%
SCOPIA CAPITAL MANAGEMENT LP 8,081,650$130,761,0002.48%
View complete list of HORIZON PHARMA PLC shareholders